Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme
Szu‐Ting Chou(Cedars-Sinai Medical Center), Julia Y. Ljubimova(Cedars-Sinai Medical Center)
Cited by 51